NCT03609723

Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,433 (actual)
• Sponsor: University Hospital, Basel, Switzerland · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.

Conditions

• Complication of Coronary Artery Bypass Graft
• Complication of Extracorporeal Circulation

Interventions

Type	Name	Description
PROCEDURE	CABG	CABG with application of a myocardial protection system (MPS ®) and using a minimal extracorporeal circulation system (MiECC) or CABG without use of a minimal extracorporeal circulation system (Off-pump coronary artery bypass grafting = OPCABG)

Timeline

• Start date: 2010-06-12
• Primary completion: 2018-12-31
• Completion: 2018-12-31
• First posted: 2018-08-01
• Last updated: 2019-08-01

Locations

1 site across 1 country: Switzerland